COVID-19 vaccine, FDA
Digest more
The U.S. Food and Drug Administration has approved British drugmaker GSK's asthma drug to treat some patients with a chronic lung disease commonly known as "smoker's lung", the company said on Thursday.
The seizures occurred in Chicago in February but were announced by the FDA in a press release on Thursday and were valued at $33.8 million.
People who regularly use the allergy medications Zyrtec or Xyzal may experience severe itching when they stop, the U.S. Food and Drug Administration said in a new warning.
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of other FDA issues currently in the political spotlight. The FDA’s budget was not mentioned in the president’s preliminary spending package,
On day 2 of an FDA advisory meeting to consider a new treatment for non–muscle invasive bladder cancer, an FDA official warns of the implications of approving based on a single-arm trial.
In his first major public remarks as commissioner of the U.S. Food and Drug Administration, Dr. Marty Makary laid out a comprehensive,
Fujirebio recently announced that the US Food and Drug Administration (FDA) has granted clearance for the company’s Lumipulse in-vitro diagnostic (IVD) test for the assessment of amyloid pathology in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline.
"Expert Panels with the FDA" are a series of roundtable discussions to provide an open public discourse on the latest medical and scientific information on several important topics. At this roundtable,